Traditionally, an initial public offering (IPO) involves selling shares of a company to the public, diluting existing ...

Women’s health is one of the most underinvested frontiers in healthcare— where capital can unlock disproportionate returns ...

Since the first day, it was a story of fighting injustice,” inDrive’s CEO Arsen Tomsky tells TIME. “That is what really ...

Private markets are becoming a bigger part of the global economy, and investors want a piece of the pie.

A Rockville immunotherapy company struck an $8 million deal to take back ownership of the drug candidates it’s been licensing from another company. The move stands to save the startup tens of millions ...

Thirteen days into January, Bill Ackman, founder and CEO of Pershing Square Capital, who doubles as a modern-day Gordon Gekko ...

OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today provided a corporate update to the marketplace to ...

Operator Good morning, and welcome to the Oatly fourth-quarter 2024 earnings conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the conference ...

Tomsky insists inDrive is not a social enterprise, saying that he may well IPO one day, though he deems it a “very ... “I also want to establish some scientific research center and hope we will find ...

A vibrant set of global IPOs will start happening ... and the US will be a leading player in this sector, not just because of research, but also due to intellectual property protection. Lastly, ...

Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...